Sandra Levy
ARTICLES BY THIS AUTHOR
- 7/12/2021
Hikma intros succinylcholine chloride injection
Succinylcholine chloride injection had a market value of roughly $43 million in the 12 months ended May 2021, according to IQVIA. - 7/12/2021
FDA tentatively approves Unichem’s generic Januvia
Unichem's generic Januvia is indicated as an adjunct to diet and exercise to improve glycemic control in adults with Type 2 diabetes mellitus. - 7/12/2021
Lupin launches generic Kerydin
Lupin's generic Kerydin is an antifungal for the treatment of onychomycosis of toenails. - 7/12/2021
Study examines cost to Medicare of delayed Humira biosimilars
The study compared the European Union system for biosimilar introduction to that of the United States and evaluated the savings that would have arisen from the presence of multiple biosimilars of Humira. - 7/12/2021
Breckenridge debuts generic Ambien CR
Ambien CR and its generics had a market value of $42 million during the 12 months ended May 2021, according to industry sales data. - 7/12/2021
Genoa Healthcare, mental health centers partner on COVID vaccinations
Genoa has administered more than 100,000 immunizations in 37 states for behavioral health patients and health care providers. - 7/11/2021
Lannett intros generic Lescol
Fluvastatin sodium ER tablets had a market value of approximately $10 million for the 12 months ended May 2021, although actual generic market values are expected to be lower, according to IQVIA. - 7/11/2021
FIP releases vaccination handbook for pharmacists
“Make every contact count” is the key message from FIP as it launches a new vaccination handbook for pharmacists. - 7/11/2021
Alembic obtains FDA nod for 2 generics
Desipramine hydrochloride tablets had a market value of roughly $7 million, while erlotinib tablets had a market value of $37 million, for the 12 months ended March 2021, according to IQVIA. - 7/11/2021
Pharmacy orgs applaud DOJ action in Washington Medicaid case
NCPA, NACDS, and WSPA are hailing a move by the Department of Justice that could signal victory in their case against low Medicaid reimbursements for pharmacies.
